Financial statements Molecular Medicine
Balance sheet of Molecular Medicine
Company age:
Age:
7 y. 3 m. 29 d.
Share capital:
Share capital:
100 000 PLN
Balance sheet data of MOLECULAR MEDICINE
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 559,00 | 267,00 | 174,00 | 266,00 | 220,00 |
| A. Fixed assets | 67,00 | 50,00 | 50,00 | 0,00 | 0,00 |
| B. Current assets | 293,00 | 217,00 | 124,00 | 266,00 | 220,00 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 559,00 | 267,00 | 174,00 | 266,00 | 220,00 |
| A. Equity | -1 145,00 | -907,00 | -433,00 | -504,00 | -375,00 |
| B. Liabilities and provisions for liabilities | 1 705,00 | 1 174,00 | 607,00 | 770,00 | 595,00 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.